ArticleBMC pregnancy and childbirth2025
Serum metabolites as diagnostic biomarkers for preterm labor: a metabolomics-based study.
Article in BMC pregnancy and childbirth, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundPreterm labor is a common high-risk condition during pregnancy, but current diagnostic approaches, such as cervical length measurement and uterine contraction monitoring, lack sufficient specificity and sensitivity. This study aims to explore potential biomarkers for threatened preterm labor using untargeted metabolomics, providing novel indicators to improve clinical diagnosis.
methodsA total of 46 pregnant women from Jiangxi Maternal and Child Health Hospital were retrospectively enrolled in case-control study and divided into a preterm birth group (n = 23) and a control group (n = 23) based on gestational age. Serum metabolic profiles were analyzed using untargeted metabolomics. Differential metabolites were identified via Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA) and P-value screening. Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis was used to explore their biological relevance. Logistic regression and Receiver Operating Characteristic (ROC) curve analysis were applied to evaluate potential biomarkers for threatened preterm labor.
resultsUsing Orthogonal Partial Least Squares Discriminant Analysis (OPLS-DA), key metabolites associated with preterm birth were identified, including cis-9-palmitoleic acid (AUC = 0.830), 2-amino-1-phenylethanol (AUC = 0.718), and phenylalanine (AUC = 0.708), as shown by ROC curves. These metabolites were significantly elevated in the preterm group and showed good diagnostic potential (AUC > 0.5).
conclusionsSeveral serum metabolites were identified as potential biomarkers for threatened preterm labor, defined by regular uterine contractions, cervical changes, and abnormal vaginal discharge before 37 weeks. These findings may aid in the early diagnosis of preterm birth.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.